• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Lipoprotein (a): a potential biological marker for unruptured intracranial aneurysms.

作者信息

Phillips J, Roberts G, Bolger C, el Baghdady A, Bouchier-Hayes D, Farrell M, Collins P

机构信息

Department of Neurosurgery, Beaumont Hospital, Dublin, Eire.

出版信息

Neurosurgery. 1997 May;40(5):1112-5; discussion 1115-7. doi: 10.1097/00006123-199705000-00067.

DOI:10.1097/00006123-199705000-00067
PMID:9149281
Abstract

OBJECTIVE

The diagnosis and treatment of intracranial aneurysms (IAs) prior to rupture reduces the high morbidity and mortality associated with their occurrence. Elevated serum lipoprotein (a) [Lp(a)] level, an independent risk factor for atherogenesis, has been demonstrated in sporadic IA disease (1). The purpose of this study was to assess the degree of correlation between elevated Lp(a) levels and the occurrence of IAs in asymptomatic first degree relatives of index cases from three families exhibiting a familial tendency towards IA development.

METHODS

25 family members and 41 healthy controls were screened by random serum Lp(a) sampling. All family members received 4-vessel cerebral angiography.

RESULTS

Eleven family members were found on angiography to harbour asymptomatic aneurysms and all were successfully treated by surgery. Of these 11, ten had significantly raised serum Lp(a) levels (> 30 mg%). Fourteen family members had negative angiograms. Eight of this latter group, mean age 43.6 +/- 3.8 years, had serum Lp(a) levels above the normal range. Mean Lp(a) levels were 53.7 +/- 1.2 mg% in subjects with aneurysms compared with 22.1 +/- 1.45 mg% in subjects without demonstrable aneurysms and 10.5 +/- 0.48 mg% in the control population.

CONCLUSION

The prevalence of elevated Lp(a) levels in these families and the high degree of association of raised Lp(a) levels with the presence of IAs in several family members warrants follow up of angiographically negative young subjects. We require a case-control study to establish whether particular polymorphisms at the apoprotein (a) gene level are associated with the occurrence of IAs in these families.

摘要

相似文献

1
Lipoprotein (a): a potential biological marker for unruptured intracranial aneurysms.
Neurosurgery. 1997 May;40(5):1112-5; discussion 1115-7. doi: 10.1097/00006123-199705000-00067.
2
Asymptomatic familial cerebral aneurysms.无症状性家族性脑动脉瘤
Neurosurgery. 1998 Oct;43(4):776-81. doi: 10.1097/00006123-199810000-00026.
3
Genetic evaluation of lipoprotein(a) in intracranial aneurysm disease.颅内动脉瘤疾病中脂蛋白(a)的基因评估
Neurosurgery. 2001 Jul;49(1):133-40; discussion 141-2. doi: 10.1097/00006123-200107000-00020.
4
Greater rupture risk for familial as compared to sporadic unruptured intracranial aneurysms.与散发性未破裂颅内动脉瘤相比,家族性未破裂颅内动脉瘤的破裂风险更高。
Stroke. 2009 Jun;40(6):1952-7. doi: 10.1161/STROKEAHA.108.542571. Epub 2009 Feb 19.
5
Clinical features of intracranial aneurysms in siblings.兄弟姐妹中颅内动脉瘤的临床特征。
Neurosurgery. 2000 Jun;46(6):1301-5; discussion 1305-6. doi: 10.1097/00006123-200006000-00004.
6
Initial and follow-up screening for aneurysms in families with familial subarachnoid hemorrhage.对家族性蛛网膜下腔出血家族中的动脉瘤进行初始筛查和随访筛查。
Neurology. 1998 Oct;51(4):1125-30. doi: 10.1212/wnl.51.4.1125.
7
Screening for unruptured familial intracranial aneurysms. A decision analysis.未破裂家族性颅内动脉瘤的筛查。一项决策分析。
Acta Neurol Scand. 1992 Oct;86(4):381-9. doi: 10.1111/j.1600-0404.1992.tb05105.x.
8
Intracranial aneurysms: MR angiographic screening in 400 asymptomatic individuals with increased familial risk.颅内动脉瘤:对400名有家族性风险增加的无症状个体进行磁共振血管造影筛查。
Radiology. 1995 Apr;195(1):35-40. doi: 10.1148/radiology.195.1.7892491.
9
MR angiography and surgery for unruptured familial intracranial aneurysms in persons with a family history of cerebral aneurysms.有脑动脉瘤家族史的未破裂家族性颅内动脉瘤的磁共振血管造影和手术治疗
AJR Am J Roentgenol. 1999 Jul;173(1):133-8. doi: 10.2214/ajr.173.1.10397113.
10
Epidemiology and genetics of intracranial aneurysms.颅内动脉瘤的流行病学和遗传学。
Eur J Radiol. 2013 Oct;82(10):1598-605. doi: 10.1016/j.ejrad.2012.12.026. Epub 2013 Feb 8.

引用本文的文献

1
Lipoprotein(a) as a Stroke Biomarker: Pathophysiological Pathways and Therapeutic Implications.脂蛋白(a)作为一种中风生物标志物:病理生理途径及治疗意义
J Clin Med. 2025 Apr 25;14(9):2990. doi: 10.3390/jcm14092990.
2
Intracranial Aneurysms and Lipid Metabolism Disorders: From Molecular Mechanisms to Clinical Implications.颅内动脉瘤与脂代谢紊乱:从分子机制到临床意义。
Biomolecules. 2023 Nov 14;13(11):1652. doi: 10.3390/biom13111652.
3
Association of aortic dissection and lipoprotein (a): a meta-analysis.主动脉夹层与脂蛋白(a)的关联:一项荟萃分析。
Ann Med Surg (Lond). 2023 May 3;85(6):2896-2905. doi: 10.1097/MS9.0000000000000725. eCollection 2023 Jun.
4
A Future Blood Test to Detect Cerebral Aneurysms.一种未来用于检测脑动脉瘤的血液检测方法。
Cell Mol Neurobiol. 2023 Aug;43(6):2697-2711. doi: 10.1007/s10571-023-01346-4. Epub 2023 Apr 12.
5
Treatment and Outcome of Patients With Coronary Artery Ectasia: Current Evidence and Novel Opportunities for an Old Dilemma.冠状动脉扩张患者的治疗与预后:旧难题的当前证据与新机遇
Front Cardiovasc Med. 2022 Feb 4;8:805727. doi: 10.3389/fcvm.2021.805727. eCollection 2021.
6
Characterization of Long Non-coding RNA Signatures of Intracranial Aneurysm in Circulating Whole Blood.颅内动脉瘤患者循环全血长链非编码 RNA 特征分析。
Mol Diagn Ther. 2020 Dec;24(6):723-736. doi: 10.1007/s40291-020-00494-3.
7
Is Lipoprotein (a) a Risk Factor for Coronary Artery Ectasia?脂蛋白(a)是冠状动脉扩张的危险因素吗?
Cardiol Res. 2020 Feb;11(1):50-55. doi: 10.14740/cr992. Epub 2020 Jan 26.
8
Circulating neutrophil transcriptome may reveal intracranial aneurysm signature.循环中性粒细胞转录组可能揭示颅内动脉瘤特征。
PLoS One. 2018 Jan 17;13(1):e0191407. doi: 10.1371/journal.pone.0191407. eCollection 2018.
9
Circulating microRNAs serve as novel biological markers for intracranial aneurysms.循环微RNA作为颅内动脉瘤的新型生物标志物。
J Am Heart Assoc. 2014 Sep 23;3(5):e000972. doi: 10.1161/JAHA.114.000972.